6728 Federal Register / Vol. 73, No.

24 / Tuesday, February 5, 2008 / Notices

by prospectively studying children who participating in a phone survey (no development, the health status, and the
were born with this potentially more than 40 minutes) or an in-person onset of complications among children
disabling condition. We estimate to assessment (no more than 2 hrs). For with SB in order that effective
enroll approximately 40 parents with a families who participate in the in- interventions may be identified that will
child with Spina Bifida ages 3-, 4-, or 5- person assessment, (estimated to be ameliorate the course of this complex,
years of age, and 20 of the children of twenty of the forty families); the child multi-system condition. Long-term
these forty parents. The data to be will also be invited to participate in a results will help determine if it would
collected will relate to medical concerns child-appropriate assessment. Data will be beneficial to systematically screen
prevalent among individuals with Spina also be collected on the actual children with Spina Bifida for certain
Bifida in the areas of neurology/ recruitment process. Results from the health related, educational and
neurosurgery, urology, and orthopedics; project will be evaluated and developmental problems that these
development and learning; nutrition disseminated to provide guidance for children are at an increased risk of
and physical growth; mobility and states that are interested in following experiencing and at what age such a
functioning; general health; and family children with Spina Bifida screening should be performed.
demographics. Families interested in prospectively. The proposed project is There will be no cost to the
participating can choose between the initial step to document the respondents other than their time.

ESTIMATE OF ANNUALIZED BURDEN HOURS

Average
Number of
Number of burden per Total burden
Respondents responses per
respondents response hours
respondent (in minutes)

Parents (phone survey) ................................................................................... 20 1 40/60 13

Parents (in-person assessment) ...................................................................... 20 1 2 40
Child (in-person assessment) .......................................................................... 20 1 1 20

Total .......................................................................................................... ........................ ........................ ........................ 73

Dated: January 25, 2008. and Obesity Prevention (CUCH) and ADDRESSES: To ensure that comments on
Maryam I. Daneshvar, insert the Division of Nutrition, Physical the information collection are received,
Acting Reports Clearance Officer, Centers for Activity, and Obesity (CUCH). OMB recommends that written
Disease Control and Prevention. Dated: January 28, 2008. comments be faxed to the Office of
[FR Doc. E8–1993 Filed 2–4–08; 8:45 am] Joseph Henderson, M.P.A., Information and Regulatory Affairs,
BILLING CODE 4163–18–P Acting Chief Operating Officer, Centers for
OMB, Attn: FDA Desk Officer, FAX:
Disease Control and Prevention (CDC). 202–395–6974, or e-mailed to
[FR Doc. 08–486 Filed 2–4–08; 8:45 am]
baguilar@omb.eop.gov. All comments
DEPARTMENT OF HEALTH AND should be identified with the OMB
BILLING CODE 4160–18–M
HUMAN SERVICES control number 0910–0551. Also
include the FDA docket number found
Centers for Disease Control and in brackets in the heading of this
DEPARTMENT OF HEALTH AND
Prevention document.
HUMAN SERVICES
Statement of Organization, Functions, FOR FURTHER INFORMATION CONTACT:
Food and Drug Administration Denver Presley Jr.,Office of the Chief
and Delegations of Authority
[Docket No. FDA–2008–N–0051] (formerly Information Officer (HFA–250), Food
Part C (Centers for Disease Control Docket No. 2007N–0422) and Drug Administration,5600 Fishers
and Prevention) of the Statement of Lane, Rockville, MD 20857, 301–827–
Organization, Functions, and Agency Information Collection 1472.
Delegations of Authority of the Activities; Submission for Office of
SUPPLEMENTARY INFORMATION: In
Department of Health and Human Management and Budget Review;
compliance with 44 U.S.C. 3507, FDA
Services (45 FR 67772–76, dated Comment Request; Application for
has submitted the following proposed
October 14, 1980, and corrected at 45 FR Participation in the Medical Device
collection of information to OMB for
69296, October 20, 1980, as amended Fellowship Program
review and clearance.
most recently at 72 FR 67308, dated AGENCY: Food and Drug Administration,
November 28, 2007) is amended to Application for Participation in the
HHS.
reflect the title change for the Division Medical Device Fellowship Program;
ACTION: Notice. (OMB Control Number 0910–0551)—
of Nutrition, Physical Activity, and
Obesity Prevention, National Center for SUMMARY: The Food and Drug Extension
Chronic Disease Prevention and Health Administration (FDA) is announcing Sections 1104, 1302, 3301, 3304,
Promotion, Coordinating Center for that a proposed collection of 3320, 3361, 3393, and 3394 of title 5 of
Health Promotion, Centers for Disease information has been submitted to the the United States Code, authorize
Control and Prevention. Office of Management and Budget Federal agencies to rate applicants for
rmajette on PROD1PC64 with NOTICES

Section C–B, Organization and (OMB) for review and clearance under Federal jobs. Collecting applications for
Functions, is hereby amended as the Paperwork Reduction Act of 1995. the Medical Device Fellowship Program
follows: DATES: Fax written comments on the will allow FDA’s Center for Devices and
Delete in its entirety the title for the collection of information by March 6, Radiological Health (CDRH) to easily
Division of Nutrition, Physical Activity, 2008. and efficiently elicit and review

VerDate Aug<31>2005 15:34 Feb 04, 2008 Jkt 214001 PO 00000 Frm 00039 Fmt 4703 Sfmt 4703 E:\FR\FM\05FEN1.SGM 05FEN1
 Federal Register / Vol. 73, No. 24 / Tuesday, February 5, 2008 / Notices
information from students and health
care professionals who are interested in
becoming involved in CDRH activities.
The process will reduce the time and
cost of submitting written
documentation to the agency and lessen
the likelihood of applications being
TABLE 1.—ESTIMATED ANNUAL REPORTING BURDEN1
5 U.S.C. Section/
FDA Form No.
1104, 1302, 3301, 3304, 3320, 3361,
3393, 3394/
Form No. 3608
1 There are no capital costs or operating and maintenance costs associated with this collection of information.
FDA based these estimates on the
number of inquiries that have been
received concerning the program and
the number of requests for application
forms over the past 3 years.
Dated: January 30, 2008.
Jeffrey Shuren,
Assistant Commissioner for Policy.
[FR Doc. E8–2068 Filed 2–4–08; 8:45 am]
BILLING CODE 4160–01–S
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2008–N–0048] (formerly
Docket No. 2007N–0182)
Agency Information Collection
Activities; Announcement of Office of
Management and Budget Approval;
Information Program on Clinical Trials
for Serious and Life-Threatening
Diseases: Maintaining a Databank
AGENCY: Food and Drug Administration,
HHS.
ACTION: Notice.
SUMMARY: The Food and Drug
Administration (FDA) is announcing
that a collection of information entitled
‘‘Information Program on Clinical Trials
for Serious and Life-Threatening
Diseases: Maintaining a Databank’’ has
been approved by the Office of
Management and Budget (OMB) under
the Paperwork Reduction Act of 1995.
FOR FURTHER INFORMATION CONTACT:
Jonna Capezzuto, Office of the Chief
Information Officer (HFA–250), Food
and Drug Administration, 5600 Fishers
Lane, Rockville, MD 20857, 301–827–
4659.
rmajette on PROD1PC64 with NOTICES
SUPPLEMENTARY INFORMATION: In the
Federal Register of October 19, 2007 (72
FR 59295), the agency announced that
the proposed information collection had
been submitted to OMB for review and
VerDate Aug<31>2005 15:34 Feb 04, 2008 Jkt 214001
misrouted within the agency mail
system. It will assist the agency in
promoting and protecting the public
health by encouraging outside persons
to share their expertise with CDRH.
In the Federal Register of November
9, 2007 (72 FR 63614), FDA published
No. of Annual Frequency
Respondents per Response
250 1 250
clearance under 44 U.S.C. 3507. An
agency may not conduct or sponsor, and
a person is not required to respond to,
a collection of information unless it
displays a currently valid OMB control
number. OMB has now approved the
information collection and has assigned
OMB control number 0910–0459. The
approval expires on January 31, 2011. A
copy of the supporting statement for this
information collection is available on
the Internet at http://www.reginfo.gov/
public/do/PRAMain.
Dated: January 30, 2008.
Jeffrey Shuren,
Assistant Commissioner for Policy.
[FR Doc. E8–2076 Filed 2–4–08; 8:45 am]
BILLING CODE 4160–01–S
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2008–N–0050]
Agency Information Collection
Activities; Proposed Collection;
Comment Request; Medical Devices;
Device Tracking
AGENCY: Food and Drug Administration,
HHS.
ACTION: Notice.
SUMMARY: The Food and Drug
Administration (FDA) is announcing an
opportunity for public comment on the
proposed collection of certain
information by the agency. Under the
Paperwork Reduction Act of 1995 (the
PRA), Federal agencies are required to
publish notice in the Federal Register
concerning each proposed collection of
information, including each proposed
extension of an existing collection of
information, and to allow 60 days for
public comment in response to the
notice. This notice solicits comments on
PO 00000 Frm 00040 Fmt 4703 Sfmt 4703
6729
a 60-day notice requesting public
comment on the information collection
provisions. No comments were received.
FDA estimate of the burden for this
collection of information is as follows:
Total Annual Hours per Total Hours
Responses Response
1 250
information collection requirements for
the tracking of medical devices.
DATES: Submit written or electronic
comments on the collection of
information by April 7, 2008.
ADDRESSES: Submit electronic
comments on the collection of
information to http://
www.regulations.gov. Submit written
comments on the collection of
information to the Division of Dockets
Management (HFA–305), Food and Drug
Administration, 5630 Fishers Lane, rm.
1061, Rockville, MD 20852. All
comments should be identified with the
docket number found in brackets in the
heading of this document.
FOR FURTHER INFORMATION CONTACT:
Denver Presley, Jr., Office of the Chief
Information Officer (HFA–250), Food
and Drug Administration,5600 Fishers
Lane, Rockville, MD 20857, 301 827–
1472.
SUPPLEMENTARY INFORMATION: Under the
PRA (44 U.S.C. 3501–3520), Federal
agencies must obtain approval from the
Office of Management and Budget
(OMB) for each collection of
information they conduct or sponsor.
‘‘Collection of information’’ is defined
in 44 U.S.C. 3502(3) and 5 CFR
1320.3(c) and includes agency requests
or requirements that members of the
public submit reports, keep records, or
provide information to a third party.
Section 3506(c)(2)(A) of the PRA (44
U.S.C. 3506(c)(2)(A)) requires Federal
agencies to provide a 60-day notice in
the Federal Register concerning each
proposed collection of information
including each proposed extension of an
existing collection of information,
before submitting the collection to OMB
for approval. To comply with this
requirement, FDA is publishing notice
of the proposed collection of
information set forth in this document.
With respect to the following
collection of information, FDA invites
E:\FR\FM\05FEN1.SGM 05FEN1